SCHEMBL5569349

SCHEMBL5569349

O=C1CCCN1c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
HTT P42858 2/20 0.55
LMNA P02545 1/20 0.55
MMP13 P45452 1/20 0.52
ALDH1A1 P00352 1/20 0.51
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
LTA4H P09960 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
KCNH2 Q12809 2/20 0.49
MCHR1 Q99705 2/20 0.49
HRH3 Q9Y5N1 3/20 0.49
NR4A1 P22736 1/20 0.49
NR4A2 P43354 1/20 0.49
NR4A3 Q92570 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5697582 0.91 MMP13 (0.54) SMN1; SMN2HTTLMNAMMP13RAB9A
SCHEMBL13097411 0.86 GRM5 (0.56) SMN1; SMN2HTTLMNAALDH1A1RAB9A
SCHEMBL5535678 0.84 MAOB (0.56) SMN1; SMN2ALDH1A1RAB9ANPC1KCNH2
SCHEMBL28570818 0.82 MAOB (0.56) SMN1; SMN2HTTLMNAMMP13KCNH2
SCHEMBL13097167 0.82 GRM5 (0.54) ALDH1A1RAB9ANPC1KCNH2MCHR1
SCHEMBL13097418 0.81 CACNA2D1 (0.54) ALDH1A1RAB9ANPC1KCNH2MCHR1
SCHEMBL3364915 0.80 MAOB (0.56) SMN1; SMN2ALDH1A1RAB9ANPC1KCNH2
SCHEMBL19086546 0.80 F10 (0.54) MMP13ALDH1A1MCHR1GAAMAPT
Hydrochloric Acid SCHEMBL6437878 0.79 KMT2A (0.44) SMN1; SMN2HTTLMNAALDH1A1RAB9A
SCHEMBL5610349 0.79 NOTUM (0.46) SMN1; SMN2HTTLMNAALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112851561-A NR6A1 protein receptor inhibitor and preparation and application thereof 南京艾美斐生物医药科技有限公司 2021-05-28 CN disclosed
US-7456210-B2 Benzyloxy derivatives HOFFMANN-LA ROCHE INC. (US) 2008-11-25 US disclosed
US-7456210-B2 Benzyloxy derivatives HOFFMANN-LA ROCHE INC. (US) 2008-11-25 US disclosed
CN-100383118-C 4-pyrrolidino-phenyl-benzyl ether derivatives HOFFMANN LA ROCHE (CH) 2008-04-23 CN disclosed
US-7235581-B2 4-pyrrolidino-phenyl-benzyl ether derivatives HOFFMAN-LA ROCHE INC. (US) 2007-06-26 US disclosed
CN-1681779-A 4-pyrrolidino-phenyl-benzyl ether derivatives HOFFMANN LA ROCHE (CH) 2005-10-12 CN disclosed
EP-1542971-A1 4-PYRROLIDINO-PHENYL-BENZYL ETHER DERIVATIVES F. Hoffmann-La Roche Ltd. (CH) 2005-06-22 EP disclosed
US-20040097578-A1 4-Pyrrolidino-phenyl-benzyl ether derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2004-05-20 US disclosed
WO-2004026826-A1 4-PYRROLIDINO-PHENYL-BENZYL ETHER DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097578-A1 4-Pyrrolidino-phenyl-benzyl ether derivatives MAOB, MAOA, COMT SMN1; SMN2 913/4885HTT 316/4885LMNA 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.